VEGFA and lung carcinoma: The results demonstrated that the VEGF -460C/T polymorphism was not significantly correlated with the risk of lung cancer only in the allele model (pooled OR = 1.04, 95% CI: 0.97–1.12, P = 0.201), homozygote model (pooled OR = 1.12, 95% CI: 0.96–1.30, P = 0.269), heterozygote model (pooled OR = 1.11, 95% CI: 0.96–1.28, P = 0.687), dominant model (pooled OR = 1.11, 95% CI: 0.97–1.27, P = 0.534), and recessive model (pooled OR = 1.02, 95% CI: 0.92–1.13, P = 0.151) (Figure 3).